Back

Size-dependent efficacy of low-voltage area ablation in persistent atrial fibrillation: a subanalysis of the SUPPRESS-AF trial

29 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation: new technologies Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Masato Okada

Sakurabashi-Watanabe Hospital, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
Long-term clinical effectiveness of pulsed field ablation in elderly patients with atrial fibrillation: sub-analysis of the global FARADISE registry
Professor A. Dello Russo (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Sex differences in long-term clinical effectiveness after pulsed field ablation to treat atrial fibrillation. Sub-analysis of the global FARADISE registry
Doctor J. Vijgen (Hasselt, BE)
Abstract Slides
Presentation thumbnail
One-year outcome using a size-adjustable cryoballoon in patients with atrial fibrillation
Mr Y. Hayashi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Impact of ablation modality on alternative efficacy endpoint definition of pulmonary vein isolation for atrial fibrillation
Mr F. Jordan (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Procedural characteristics of very high-power short-duration compared to ablation index-guided ablation for pulmonary vein isolation in atrial fibrillation patients
Ms N. Van Pouderoijen (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation: new technologies

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
The efficacy of low-voltage-area ablation enhances in patients with advanced left atrial enlargement: a subanalysis of SUPPRESS-AF trial
thumbnail
Congress Presentation
Discussant review - SUPPRESS-AF
thumbnail
Congress Presentation
Prognostic value of atrial fibrillation duration and left atrial low-voltage area after atrial fibrillation ablation: insights from the SUPPRESS AF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources